No Data
No Data
Stocks that moved on the previous day, part 1, include Jade G, Kokusai Electric, Mercari, etc.
Stock name <code> 5-day closing price ⇒ Previous day comparison boom <2303> 2149 + 91 Tiwaki, which develops and provides Edge AI services, has entered into a capital business alliance. Kayuso Distribution <9369> 1792 + 10224 upwardly revised earnings forecast for the fiscal year ending November 11, 2024. Tohse <4728> 689-3124 adversely revised earnings forecast for the fiscal year ending August 2024. JADE G <3558> 1922 + 2973 Magaseek, which became a consolidated subsidiary in March, has improved its performance. INCLUSIVE <7078>
Active and newly established stocks in the afternoon session.
* Dawn <2303> 2149 +91 Capital business tie-up with tiwaki, which develops and provides Edge AI services. * Kiyuso Distribution <9369> 1792 +102 upward revision of fiscal year 2024 earnings estimates. * Tohse <4728> 689 -31 downward revision of fiscal year 2024 earnings estimates. * Jade G <3558> 1922 +297 Improvement of Magaseek's performance, which was consolidated subsidiary in March. * INCLUSIVE <7078> 716 +22 AI · W
Investment Strategy for July 5th [Today]
[FISCO Selected Stock][Material Stock] Aoki Holdings, a drugstore company with a strong presence in Hokuriku, is trading at 2,905.5 yen (as of 7/4). The company announced its financial results for the fiscal year ending in May 2024, with operating profit of 18.5 billion yen (+21.4% YoY), exceeding the previous financial estimate of 17.2 billion yen. For the fiscal year ending in May 2025, the expected operating profit is 25.1 billion yen (+35.2% YoY). They are planning to open new drugstores in 70 locations and aim to handle fresh produce, meat and ready-made meals in all stores except for the small ones.
Attention on Euglena and Kewpie, Honda and Arx are weak.
The US stock market was closed on the 4th. The exchange rate was 1 dollar = 161.20-30 yen. In today's Tokyo market, Aoki Pharmaceuticals <3549> announced that it expects its operating profit to increase by 35.2% this year, up 21.4% from the previous period. Kewpie <2809> revised its performance forecast for the fiscal year ending November 2024 and announced an increase in dividends. Euglena <2931> announced that it has established the world's first algal breeding technology using neutron irradiation. In the Tokyo Stock Exchange standard market, Chiyo Distribution <...> revised its performance forecast for the fiscal year ending November 2024 upward.
Stocks with attractive features based on volume changes, such as Tim's, etc.
Stock Closing Price Changes from Previous Day Volume <9238>Value C 1270 +262 1,861,600 <4889>Renascience 365 +21 2,182,700 <4891>Tim's 244 +7 9,284,600 <6835>Allied HD 101 +4 2,278,900 <4728>Toase 720 +28 39,200 <9562>Business Coach 1 -
Kewpie revised its forecast upwards on November 24, with an operating profit of ¥34 billion, up from ¥31 billion.
Kewpie Corporation <2809> announced a revision of its financial estimates for the November 2024 fiscal year. The revenue has been upwardly revised from JPY 480 billion to JPY 486 billion, and the operating profit from JPY 31 billion to JPY 34 billion. This progress was due to sales growth in each segment of commercial, industrial, and overseas, as well as resulting improvements in earnings that exceeded initial expectations. In addition, we have revised our dividend forecast, and the expected dividend per share at the end of the period has been revised upward from JPY 27 per share to JPY 31 per share, an increase of JPY 4 per share. (Annual dividend from JPY 50 to JPY 54).
No Data